Logindo Samudramakmur Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Logindo Samudramakmur Tbk. trades at Rp101 (market cap 574.16B, 12.07M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.57M versus 12.07M). Which is the better fit depends on your goals.
| LEAD | RSCH | |
|---|---|---|
Market Cap | 574.16B | 678.4B |
Volume | 12.07M | 25.57M |
Lot | 120.69K | 255.67K |
Turnover | 1.2B | 6.57B |
Average Price | 99.77 | 256.8 |
Value | 1.2B | 6.57B |
Indicative Equilibrium Price | 101 | 258 |
Indicative Equilibrium Volume | 3.23K | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Read more on LEAD →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →